How will the Trump administration’s cuts to HIV analysis influence the progress that is been made in the direction of ending the epidemic within the U.S.?
PIEN HUANG, HOST:
Throughout his first time period, President Trump laid out a daring proposal throughout a State of the Union deal with.
(SOUNDBITE OF ARCHIVED RECORDING)
PRESIDENT DONALD TRUMP: My funds will ask Democrats and Republicans to make the wanted dedication to eradicate the HIV epidemic in the US inside 10 years. We’ve got made unimaginable strides, unimaginable.
(APPLAUSE)
HUANG: The Trump administration’s aim of eliminating HIV within the U.S. led to a swell of analysis and funding to review the virus. However within the opening months of his second time period, the Trump administration slashed 1000’s of Public Well being jobs and gutted funding for scientific analysis, together with grants and funds for HIV and AIDS analysis. What does this imply for the way forward for HIV analysis within the U.S.? Dr. John Brooks is the previous chief medical officer to the CDC’s division of HIV prevention, and he joins me now. Dr. Brooks, welcome to ALL THINGS CONSIDERED.
JOHN BROOKS: Properly, Pien, thanks. It is a pleasure to be right here, and I admire your consideration to this subject.
HUANG: So initially, are you able to give us a way of the place HIV analysis stood earlier than these cuts?
BROOKS: Properly, you realize, HIV analysis has been in place for the reason that discovery of the virus as the reason for superior HIV illness, which we used to name AIDS. And it is, you realize, made unimaginable strides. We are actually at a spot, attributable to constant funding by largely federal assist, that is found wonderful medication that may assist us each deal with HIV to maintain an individual wholesome but in addition to forestall HIV.
HUANG: Have been there any remedies that we had been type of – you realize, you are speaking about remedies which were developed and are on the market working for folks. Was there something additionally that was within the works that we’ve not fairly gotten to but?
BROOKS: Yeah, so a few crucial issues. To begin with, there was a decadeslong pursuit of an HIV vaccine, and that analysis, in addition to analysis for an HIV treatment, seems to have been canceled. That was largely analysis funded by the NIH. A vaccine could be unimaginable if we may have it – monumental public well being influence, gigantic financial advantages, in addition to the scientific developments it’ll present and has supplied previously. Ditto for an HIV treatment. Secondly, the way in which that we can provide folks medication, each to deal with their an infection and to guard folks from getting contaminated, are advancing very quickly. A brand new drug, lenacapavir, has lately been accepted not just for treating but in addition for stopping HIV. And uniquely, it is easy to manage. It is about as straightforward to manage as a vaccine, and it may possibly shield an individual for as much as six months.
HUANG: So decreasing or eliminating HIV requires a two-pronged strategy. There’s the prevention a part of it after which the remedy a part of it. And I am questioning the way you see these cuts impacting every of these approaches.
BROOKS: One of many issues that worries me is that the main target of the present administration with regard to HIV – which by the way is included as a brand new a part of the Administration for a Wholesome America – that HIV bureau or division, no matter it is finally named, appears extremely centered on simply remedy. However I feel these of us who work in infectious ailments know effectively that remedy isn’t going to be the way in which you are going to get out of any epidemic. Prevention is an important part. And what we’re seeing now could be notably round prevention analysis and prevention actions, an actual discount in what’s being executed.
HUANG: So given the place we’re, and that, you realize, the truth that Trump’s initiative to eradicate HIV within the U.S. continues to be being funded, such as you mentioned, possibly below the brand new Administration for a Wholesome America, whilst different HIV analysis is being reduce, do you suppose the U.S. can nonetheless attain this aim of eliminating HIV by 2030?
BROOKS: Properly, I am a born optimist, and I’m hopeful. However actually, I feel that with the cuts being made in analysis and, particularly, the exceptional and, for my part, draconian cuts being made to federal funding in HIV prevention, are going to result in a rise in new HIV infections nationally. We’ve got made nice strides on this nation below the president’s first-term signature initiative to eradicate the HIV epidemic in America. Within the first 4 years that it was in impact, we have seen a 12% decline in new infections nationally and a 19% decline in deaths attributable to HIV.
HUANG: It appears like what you are saying, Dr. Brooks, is that present HIV sufferers will nonetheless have the ability to entry remedy, however you are notably anxious concerning the prevention a part of it, the prevention of latest folks from getting HIV. Is that proper?
BROOKS: That is completely proper. You recognize, PrEP, this remedy that’s given to forestall an infection – it stands for pre-exposure prophylaxis – has made terrific advances. There is a new drug that is on the market that you simply solely need to take twice a yr by injection that may be administered as simply as a vaccine. Nonetheless, the drug could also be out there, and it could be very potent, however not all people has entry to it. To succeed in this drug and to get that safety, it’s worthwhile to remember that you’re in danger for HIV and be taught that you do not have HIV, so the drug can shield you. And then you definately want to have the ability to get to a spot that may administer it, you want to have the ability to afford it, and also you want to have the ability to keep engaged within the type of care that it’s worthwhile to administer the drug so long as you want it.
HUANG: That is Dr. John Brooks, former chief medical officer to the CDC’s Division of HIV Prevention. Dr. Brooks, thanks for becoming a member of us.
BROOKS: Thanks very a lot. Take care.
Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
Accuracy and availability of NPR transcripts might fluctuate. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its authentic broadcast or publication. The authoritative file of NPR’s programming is the audio file.